Next Generation Protein Therapeutics

Event date 27 September 2010 – 28 September 2010

Location Sheraton Brussels Hotel Brussels, Belgium

Spotlight Presentation 29th September, 10.15 : Real Time Cell Surface Interaction Analysis Dr. Miriam Dwek , Senior Lecturer in Biochemistry, Department of Molecular & Applied Biosciences, University of Westminster will present drug conjugate data using the Attana Cell 200 – the first system to permit real-time kinetic analysis of molecular interactions directly on cell surfaces, bridging the gap between traditional biosensors and cell based assays. Attana will also be present in the exhibition area, giving conference participants the opportunity to see the Attana Cell 200 instrument firsthand. For 25% delegate discount please click here: /www.informaglobalevents.com/newsletter/index/id/293258/member// Event homepage: http://www.informaglobalevents.com/event/nextgen

Categories

  • qcm
  • attana
  • biosensor

Related media

Related content

  • PEGS 2010 with Attana!

    We are happy to have met so many industry people during the Protein Engineering Summit 2010 in Boston last week, and if you were there but didn't get the chance to taste our exquisite espresso you are welcome to stop by our booth during our upcoming events!

  • Attana's Story told by CEO and co-founder Dr. Teodor Aastrup

    When we founded Attana in 2002, we had a dream of creating a tool that could mimic reality. We were set to do this by developing an instrument capable of measuring biological interactions exactly as the actual events in the human body.

  • Fight against cancer - Attana's collaborator interviewed

    Attana's collaborator at Gothenburg University, Dr. Sture Lindegren, is interviewed about a possible new cure for ovarian cancers. Using the Attana Cell 200 instrument, Dr. Lindegren and his team are testing antibodies as carriers of radionuclide that target cancer cells directly instead of affecting the whole body as current cancer therapies do.

  • Biotech companies - Ways to work more efficiently

    Ernst & Young recently released their 24th annual report Beyond borders: global biotechnology report 2010, presenting, among other things, five guiding principles for biotech companies working in the new economy where funding is scarce and customers careful:

  • Universities and Innovation

    We consider it strategically important to keep collaborating with our customers, university researchers in particular, to stay on top and keep getting inspired.

  • Attana - inspiring health

    At Attana we aim at improving health in society by helping our customers in their scientific research, whether they are university researchers or pharmaceutical companies developing efficient treatment against severe diseases. However, another way to stay healthy is to eat wisely and exercise, and we Attanians exercise in abundance. For instance, several years in a row Attana has...

Related events

Enter your email address to follow Attana AB

When you choose to create a user account and follow a newsroom your personal data will be used by us and the owner of the newsroom, for you to receive news and updates according to your subscription settings.

To learn more about this, please read our Privacy Policy, which applies to our use of your personal data, and our Privacy Policy for Contacts, which applies to the use of your personal data by the owner of the newsroom you follow.

Please note that our Terms of Use apply to all use of our services.

You can withdraw your consent at any time by unsubscribing or deleting your account.
Check your inbox

Email sent to __email__. Click the link there to follow Attana AB.

Okay